There are concerns that ozempic-style drugs, also known as glp-1 drugs, may pose mental health risks. Some reports suggest a potential link to suicidal thoughts, prompting calls for warning labels and regulatory action. The full scope of risks and benefits associated with these weight-loss drugs is still being explored and debated.